OAJ
MRNA icon

Ogorek Anthony Joseph’s Moderna MRNA Stock Holding History

Ogorek Anthony Joseph’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66K Sell
950
-53
-5% -$2.74K 0.02% 152
2026
Q1 		$50K Buy
1,003
+137
+16% +$6.39K 0.01% 161
2025
Q4 		$25K Sell
866
-192
-18% -$5.22K 0.01% 247
2025
Q3 		$27K Buy
1,058
+80
+8% +$2.23K 0.01% 239
2025
Q2 		$26K Buy
978
+41
+4% +$1.08K 0.01% 237
2025
Q1 		$26K Buy
937
+89
+10% +$3.16K 0.01% 232
2024
Q4 		$35K Buy
848
+137
+19% +$6.55K 0.01% 139
2024
Q3 		$47K Buy
711
+99
+16% +$9.09K 0.02% 119
2024
Q2 		$72K Hold
612
– – 0.03% 87
2024
Q1 		$65K Buy
612
+340
+125% +$34.3K 0.02% 94
2023
Q4 		$27K Buy
+272
New +$22.9K 0.01% 151

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Ogorek Anthony Joseph's MRNA Position: Q2 2026 in Review

Ogorek Anthony Joseph reduced its Moderna (MRNA) stake by 5.3% in Q2 2026, selling an estimated $2.74K and leaving 950 shares worth $66K. The position accounts for 0.02% of the portfolio, ranked #152.

Ogorek Anthony Joseph first reported a position in MRNA in Q4 2023 and has held it in 11 quarters since. The position peaked at $72K in Q2 2024. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Ogorek Anthony Joseph held 950 shares of Moderna worth $66K as of Q2 2026.
  • Ogorek Anthony Joseph sold 53 Moderna shares in Q2 2026, an estimated $2.74K.
  • Moderna made up 0.02% of Ogorek Anthony Joseph's portfolio in Q2 2026, its #152 holding.
  • Ogorek Anthony Joseph first reported a position in Moderna in Q4 2023 and has held it in 11 quarters since.
  • Ogorek Anthony Joseph's Moderna position peaked at $72K in Q2 2024.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Ogorek Anthony Joseph's 13F filing for Q2 2026, filed 7 Aug 2026.